In particular, BRAF mutations and MAPK hyperactivation induce melanoma cell proliferation, mitochondrial alterations and drive metabolism switching from OXPHOS to glycolysis and support high metabolic flexibility [70, 71]. The gene discussed is BRAF; the disease is melanoma.